Discover the detailed record of transactions filed by Shulman Joseph, Chief Technical Officer. Director active across 1 company, notably Rhythm Pharmaceuticals, INC.. Cumulatively, 31 reports have been published. Split: 0 buy · 6 sells. Total volume traded: €1.9m. Activity tracked since 9 February 2023. The latest transaction was disclosed on 13 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Shulman Joseph
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Shulman Joseph is Chief Technical Officer at Rhythm Pharmaceuticals, INC. (XNAS). He has reported 29 filings in total, and in the sampled recent filings the period runs from 2022-02-15 to 2026-02-03, with EUR 0 of buys and EUR 1,367,760 of sells, the most frequent transaction nature being Levée d'options.